BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25420445)

  • 1. HF ultrasound vs PET-CT and telethermography in the diagnosis of In-transit metastases from melanoma: a prospective study and review of the literature.
    Solivetti FM; Desiderio F; Guerrisi A; Bonadies A; Maini CL; Di Filippo S; D'Orazi V; Sperduti I; Di Carlo A
    J Exp Clin Cancer Res; 2014 Nov; 33(1):96. PubMed ID: 25420445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
    Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
    Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
    Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
    Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of FDG-PET in the assessment of survival prognosis in melanoma.
    Pleiss C; Risse JH; Biersack HJ; Bender H
    Cancer Biother Radiopharm; 2007 Dec; 22(6):740-7. PubMed ID: 18158764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.
    Jouvet JC; Thomas L; Thomson V; Yanes M; Journe C; Morelec I; Bracoud L; Durupt F; Giammarile F; Berthezene Y
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):176-85. PubMed ID: 23331931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
    Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
    Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of Positron Emission Tomography/Computed Tomography and Ultrasound Imaging for Detection of Internal Mammary Lymph Node Metastases in Patients With Breast Cancer and Pathologic Correlation by Ultrasound-Guided Biopsy Procedures.
    An YY; Kim SH; Kang BJ; Lee AW
    J Ultrasound Med; 2015 Aug; 34(8):1385-94. PubMed ID: 26206824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography/computed tomography (TEP/CT) and CT].
    Dellestable P; Granel-Brocard F; Rat AC; Olivier P; Régent D; Schmutz JL
    Ann Dermatol Venereol; 2011 May; 138(5):377-83. PubMed ID: 21570561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
    Gellén E; Sántha O; Janka E; Juhász I; Péter Z; Erdei I; Lukács R; Fedinecz N; Galuska L; Remenyik É; Emri G
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1938-44. PubMed ID: 25753249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integrated role of ultrasonography in the diagnosis of soft tissue metastases from melanoma: preliminary report of a single-center experience and literature review.
    Covarelli P; Burini G; Barberini F; Caracappa D; Boselli C; Noya G; Castellani E; Rulli A
    In Vivo; 2013; 27(6):827-33. PubMed ID: 24292589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
    Bastiaannet E; Uyl-de Groot CA; Brouwers AH; van der Jagt EJ; Hoekstra OS; Oyen W; Verzijlbergen F; van Ooijen B; Thompson JF; Hoekstra HJ
    Ann Surg; 2012 Apr; 255(4):771-6. PubMed ID: 22367443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma.
    Bastiaannet E; Hoekstra HJ; Hoekstra OS
    Methods Mol Biol; 2011; 727():123-39. PubMed ID: 21331932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
    Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
    Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole body PET/CT for initial staging of choroidal melanoma.
    Finger PT; Kurli M; Reddy S; Tena LB; Pavlick AC
    Br J Ophthalmol; 2005 Oct; 89(10):1270-4. PubMed ID: 16170114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP; David S; Alamgeer M; Ganju V
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging.
    Bronstein Y; Ng CS; Rohren E; Ross MI; Lee JE; Cormier J; Johnson VE; Hwu WJ
    AJR Am J Roentgenol; 2012 Apr; 198(4):902-8. PubMed ID: 22451559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.
    Niebling MG; Bastiaannet E; Hoekstra OS; Bonenkamp JJ; Koelemij R; Hoekstra HJ
    Ann Surg Oncol; 2013 Sep; 20(9):3098-105. PubMed ID: 23612885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography/ computed tomography for N-and M-staging of malignant melanoma].
    Gu H; Xu W; Song X; Dai D; Zhu L; Wang J
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(17):1309-12. PubMed ID: 25142850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.